Your browser doesn't support javascript.
loading
High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin.
Litmeyer, Anne-Sophie; Konukiewitz, Björn; Kasajima, Atsuko; Foersch, Sebastian; Schicktanz, Felix; Schmitt, Maxime; Kellers, Franziska; Grass, Albert; Jank, Paul; Lehman, Bettina; Gress, Thomas M; Rinke, Anja; Bartsch, Detlef K; Denkert, Carsten; Weichert, Wilko; Klöppel, Günter; Jesinghaus, Moritz.
Afiliación
  • Litmeyer AS; Institute of Pathology, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Konukiewitz B; Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universität zu Kiel, Kiel, Germany.
  • Kasajima A; Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Foersch S; Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Schicktanz F; Institute of Pathology, University Hospital Mainz, Mainz, Germany.
  • Schmitt M; Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Kellers F; Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Grass A; Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universität zu Kiel, Kiel, Germany.
  • Jank P; Institute of Pathology, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Lehman B; Institute of Pathology, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Gress TM; Department of Surgery, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Rinke A; Department of Gastroenterology, Endocrinology and Infectious Diseases, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Bartsch DK; Department of Gastroenterology, Endocrinology and Infectious Diseases, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Denkert C; Department of Surgery, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Weichert W; Institute of Pathology, Phillips University Marburg and University Hospital Marburg, Marburg, Germany.
  • Klöppel G; Institute of Pathology, Technical University of Munich, Munich, Germany.
  • Jesinghaus M; Institute of Pathology, Technical University of Munich, Munich, Germany.
J Pathol Clin Res ; 9(6): 498-509, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37608427
ABSTRACT
Complementary to synaptophysin and chromogranin A, insulinoma-associated protein 1 (INSM1) has emerged as a sensitive marker for the diagnosis of neuroendocrine neoplasms. Since there are no comparative data regarding INSM1 expression in conventional colorectal adenocarcinomas (CRCs) and colorectal mixed adenoneuroendocrine carcinomas/neuroendocrine carcinomas (MANECs/NECs), we examined INSM1 in a large cohort of conventional CRCs and MANECs/NECs. In conventional CRC, we put a special focus on conventional CRC with diffuse expression of synaptophysin, which carry the risk of being misinterpreted as a MANEC or a NEC. We investigated INSM1 according to the immunoreactive score in our main cohort of 1,033 conventional CRCs and 21 MANECs/NECs in comparison to the expression of synaptophysin and chromogranin A and correlated the results with clinicopathological parameters and patient survival. All MANECs/NECs expressed INSM1, usually showing high or moderate expression (57% high, 34% moderate, and 9% low), which distinguished them from conventional CRCs, which were usually INSM1 negative or low, even if they diffusely expressed synaptophysin. High expression of INSM1 was not observed in conventional CRCs. Chromogranin A was negative/low in most conventional CRCs (99%), but also in most MANECs/NECs (66%). Comparable results were observed in our independent validation cohorts of conventional CRC (n = 274) and MANEC/NEC (n = 19). Similar to synaptophysin, INSM1 expression had no prognostic relevance in conventional CRCs, while true MANEC/NEC showed a highly impaired survival in univariate and multivariate analyses (e.g. disease-specific survival p < 0.001). MANECs/NECs are a highly aggressive variant of colorectal cancer, which must be reliably identified. High expression of INSM1 distinguishes MANEC/NEC from conventional CRCs with diffuse expression of the standard neuroendocrine marker synaptophysin, which do not share the same dismal prognosis. Therefore, high INSM1 expression is a highly specific/sensitive marker that is supportive for the diagnosis of true colorectal MANEC/NEC.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pathol Clin Res Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pathol Clin Res Año: 2023 Tipo del documento: Article País de afiliación: Alemania
...